RDYNYSEPharmaceutical PreparationsFiscal year ends March 31

DR REDDYS LABORATORIES LTD

Financials through fiscal 2026, year ended Mar 31, 2026

$13.08+0.01 (+0.08%)

Close on Oct 19, 2026

DR REDDYS LABORATORIES LTD balance sheet

Annual Quarterly

INR USD

Millions of INR, except per-share data. Shares in millions.

Line item	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31	FY 2021 2021-03-31	FY 2020 2020-03-31	FY 2019 2019-03-31	FY 2018 2018-03-31	FY 2017 2017-03-31	FY 2016 2016-03-31	FY 2015 2015-03-31
Cash & Equivalents	15,368	14,654	7,107	5,779	14,852	14,829	2,053	2,228	2,638	3,866	–	–
Cash & Short-Term Investments	15,368	14,654	7,107	5,779	14,852	14,829	2,053	2,228	2,638	3,866	–	–
Receivables	101,219	90,420	80,298	72,485	66,764	49,641	50,278	39,869	40,617	38,065	–	–
Inventory	76,531	71,085	63,552	48,670	50,884	45,412	35,066	33,579	29,089	28,529	–	–
Other Current Assets	36,256	30,142	22,560	20,069	13,902	14,509	13,802	12,536	14,301	11,970	–	–
Total Current Assets	301,975	250,112	248,049	204,253	181,856	148,249	130,370	114,501	109,645	100,375	–	–
Property, Plant & Equipment	115,930	97,761	76,886	66,462	62,169	57,111	52,332	54,088	57,869	57,160	–	–
Operating Lease Right-of-Use Assets	12,743	4,427	3,007	1,806	2,401	2,944	1,389	–	–	–	–	–
Goodwill	12,893	11,810	4,253	4,245	4,418	4,568	3,994	3,902	3,945	3,752	–	–
Intangible Assets	105,059	96,803	36,951	30,849	27,246	35,648	27,659	44,367	44,665	44,925	20,796	–
Deferred Tax Assets	22,436	18,508	10,774	7,196	8,204	10,630	12,214	4,168	3,628	5,580	–	–
Other Long-Term Assets	1,226	972	1,632	800	894	834	844	946	1,030	983	–	–
Total Assets	579,346	492,989	387,518	321,854	292,827	265,491	232,241	225,427	225,604	219,821	–	–
Accounts Payable	33,411	35,523	30,919	26,444	25,572	23,744	16,659	14,553	16,052	13,417	–	–
Short-Term Debt	59,135	38,045	12,723	7,390	27,082	23,136	16,441	12,125	25,466	43,539	–	–
Current Portion of Long-Term Debt	6,003	857	1,307	4,804	1,017	864	4,266	4,256	63	110	–	–
Current Debt	65,138	38,902	14,030	12,194	28,099	24,000	20,707	16,381	25,529	43,649	–	–
Current Income Taxes Payable	4,310	3,028	2,342	2,144	1,615	1,389	573	181	1,530	1,483	–	–
Other Current Liabilities	50,259	45,485	42,897	39,472	33,992	30,488	29,382	24,351	22,668	21,845	–	–
Total Current Liabilities	167,566	130,392	96,039	85,845	94,015	83,391	72,814	59,700	69,692	85,000	–	–
Long-Term Debt	12,203	7,864	5,990	1,278	5,746	6,299	1,304	22,000	25,089	5,449	–	–
Operating Lease Liabilities	5,436	–	–	–	–	3,363	1,787	609	–	–	–	–
Deferred Tax Liabilities	15,568	14,108	909	833	60	338	275	610	730	1,204	–	–
Other Long-Term Liabilities	3,443	3,303	3,969	2,848	2,422	2,343	2,806	2,868	3,580	4,077	–	–
Total Liabilities	198,889	155,823	106,968	90,863	102,300	92,429	77,253	85,230	99,144	95,777	–	–
Total Debt	77,341	46,766	20,020	13,472	33,845	30,299	22,011	38,381	50,618	49,098	–	–
Common Stock	835	834	834	833	832	832	831	830	830	829	853	–
Additional Paid-In Capital	11,364	11,133	10,765	9,688	9,280	8,887	8,495	8,211	7,790	7,359	–	–
Retained Earnings	351,984	315,793	265,257	215,593	175,712	156,023	144,247	128,646	113,865	108,051	–	–
Treasury Stock	-1,815	-2,264	-991	-1,269	-1,601	-1,967	-1,006	-535	0	–	–	–
Shareholders' Equity	377,063	333,388	280,550	–	–	–	–	–	–	–	–	–
Noncontrolling Interest	3,394	3,778	0	–	–	–	–	–	–	–	–	–
Total Equity	380,457	337,166	280,550	230,991	190,527	173,062	154,988	140,197	126,460	124,044	128,336	111,302
Total Liabilities & Equity	579,346	492,989	387,518	321,854	292,827	265,491	232,241	225,427	225,604	219,821	–	–
Shares Outstanding(shares)	832	833	831	830	829	829	829	830	829	853	852	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Mar 31, 2026

Profitability, FY2026

Gross margin: 52.8%
Operating margin: 15.0%
Net margin: 12.8%
Return on equity, FY2026: 12.1%

Financial strength

Current ratio: 1.80
Debt to equity: 0.21
Debt to assets: 13.3%
Cash to current liabilities: 9.2%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.